Copyright Reports & Markets. All rights reserved.

Global Childhood Absence Epilepsy Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Childhood Absence Epilepsy Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Ethosuximide
      • 1.4.3 Valproate
      • 1.4.4 Lamotrigine
      • 1.4.5 CX-8998
      • 1.4.6 Cannabidiol Oral Solution
    • 1.5 Market by Application
      • 1.5.1 Global Childhood Absence Epilepsy Treatment Market Share by Application (2014-2025)
      • 1.5.2 Typical Absence Seizures
      • 1.5.3 Atypical Absence Seizures
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Childhood Absence Epilepsy Treatment Market Size
    • 2.2 Childhood Absence Epilepsy Treatment Growth Trends by Regions
      • 2.2.1 Childhood Absence Epilepsy Treatment Market Size by Regions (2014-2025)
      • 2.2.2 Childhood Absence Epilepsy Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Childhood Absence Epilepsy Treatment Market Size by by Players
      • 3.1.1 Global Childhood Absence Epilepsy Treatment Revenue by by Players (2014-2019)
      • 3.1.2 Global Childhood Absence Epilepsy Treatment Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Childhood Absence Epilepsy Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Childhood Absence Epilepsy Treatment Key Players Head office and Area Served
    • 3.3 Key Players Childhood Absence Epilepsy Treatment Product/Solution/Service
    • 3.4 Date of Enter into Childhood Absence Epilepsy Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Childhood Absence Epilepsy Treatment Market Size by Type (2014-2019)
    • 4.2 Global Childhood Absence Epilepsy Treatment Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Childhood Absence Epilepsy Treatment Market Size (2014-2019)
    • 5.2 Childhood Absence Epilepsy Treatment Key Players in United States
    • 5.3 United States Childhood Absence Epilepsy Treatment Market Size by Type
    • 5.4 United States Childhood Absence Epilepsy Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Childhood Absence Epilepsy Treatment Market Size (2014-2019)
    • 6.2 Childhood Absence Epilepsy Treatment Key Players in Europe
    • 6.3 Europe Childhood Absence Epilepsy Treatment Market Size by Type
    • 6.4 Europe Childhood Absence Epilepsy Treatment Market Size by Application

    7 China

    • 7.1 China Childhood Absence Epilepsy Treatment Market Size (2014-2019)
    • 7.2 Childhood Absence Epilepsy Treatment Key Players in China
    • 7.3 China Childhood Absence Epilepsy Treatment Market Size by Type
    • 7.4 China Childhood Absence Epilepsy Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Childhood Absence Epilepsy Treatment Market Size (2014-2019)
    • 8.2 Childhood Absence Epilepsy Treatment Key Players in Japan
    • 8.3 Japan Childhood Absence Epilepsy Treatment Market Size by Type
    • 8.4 Japan Childhood Absence Epilepsy Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Childhood Absence Epilepsy Treatment Market Size (2014-2019)
    • 9.2 Childhood Absence Epilepsy Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Childhood Absence Epilepsy Treatment Market Size by Type
    • 9.4 Southeast Asia Childhood Absence Epilepsy Treatment Market Size by Application

    10 India

    • 10.1 India Childhood Absence Epilepsy Treatment Market Size (2014-2019)
    • 10.2 Childhood Absence Epilepsy Treatment Key Players in India
    • 10.3 India Childhood Absence Epilepsy Treatment Market Size by Type
    • 10.4 India Childhood Absence Epilepsy Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Childhood Absence Epilepsy Treatment Market Size (2014-2019)
    • 11.2 Childhood Absence Epilepsy Treatment Key Players in Central & South America
    • 11.3 Central & South America Childhood Absence Epilepsy Treatment Market Size by Type
    • 11.4 Central & South America Childhood Absence Epilepsy Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Pfizer
      • 12.1.1 Pfizer Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Childhood Absence Epilepsy Treatment Introduction
      • 12.1.4 Pfizer Revenue in Childhood Absence Epilepsy Treatment Business (2014-2019)
      • 12.1.5 Pfizer Recent Development
    • 12.2 GlaxoSmithKline
      • 12.2.1 GlaxoSmithKline Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Childhood Absence Epilepsy Treatment Introduction
      • 12.2.4 GlaxoSmithKline Revenue in Childhood Absence Epilepsy Treatment Business (2014-2019)
      • 12.2.5 GlaxoSmithKline Recent Development
    • 12.3 Cavion Inc
      • 12.3.1 Cavion Inc Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Childhood Absence Epilepsy Treatment Introduction
      • 12.3.4 Cavion Inc Revenue in Childhood Absence Epilepsy Treatment Business (2014-2019)
      • 12.3.5 Cavion Inc Recent Development
    • 12.4 AbbVie
      • 12.4.1 AbbVie Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Childhood Absence Epilepsy Treatment Introduction
      • 12.4.4 AbbVie Revenue in Childhood Absence Epilepsy Treatment Business (2014-2019)
      • 12.4.5 AbbVie Recent Development
    • 12.5 Teva Pharmaceutical
      • 12.5.1 Teva Pharmaceutical Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Childhood Absence Epilepsy Treatment Introduction
      • 12.5.4 Teva Pharmaceutical Revenue in Childhood Absence Epilepsy Treatment Business (2014-2019)
      • 12.5.5 Teva Pharmaceutical Recent Development
    • 12.6 Insys Therapeutics
      • 12.6.1 Insys Therapeutics Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Childhood Absence Epilepsy Treatment Introduction
      • 12.6.4 Insys Therapeutics Revenue in Childhood Absence Epilepsy Treatment Business (2014-2019)
      • 12.6.5 Insys Therapeutics Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Childhood absence epilepsy (CAE), also known as pyknolepsy, is an idiopathic generalized epilepsy which occurs in otherwise normal children. The age of onset is between 4–10 years with peak age between 5–7 years. Children have absence seizures which although brief (~4–20 seconds), they occur frequently, sometimes in the hundreds per day. The absence seizures of CAE involve abrupt and severe impairment of consciousness. Mild automatisms are frequent, but major motor involvement early in the course excludes this diagnosis. The EEG demonstrates characteristic "typical 3Hz spike-wave" discharges. Prognosis is excellent in well-defined cases of CAE with most patients "growing out" of their epilepsy.
      In 2018, the global Childhood Absence Epilepsy Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Childhood Absence Epilepsy Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Childhood Absence Epilepsy Treatment development in United States, Europe and China.

      The key players covered in this study
      Pfizer
      GlaxoSmithKline
      Cavion Inc
      AbbVie
      Teva Pharmaceutical
      Insys Therapeutics
      ...

      Market segment by Type, the product can be split into
      Ethosuximide
      Valproate
      Lamotrigine
      CX-8998
      Cannabidiol Oral Solution

      Market segment by Application, split into
      Typical Absence Seizures
      Atypical Absence Seizures

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Childhood Absence Epilepsy Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Childhood Absence Epilepsy Treatment development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Childhood Absence Epilepsy Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now